Home
About JOINN
Solutions
By Service Type
Research Animals & Models
Discovery Services
R&D and Production
Safety Assessment
Clinial Trials
Laboratory services
PV Services
By Molecule Type
Biological products
Small molecule
Vaccine
By Treatment Area
Tumor
CNS
inflammation
Infectious Diseases
immunology
Cardiovascular disease
By Industry
Food science and veterinary drug evaluation
New chemicals and pesticides
Medical Devices
medicine
By Research Phase
drug screening
Production process
Non clinical research
clinical research
News & Events
Company news
Public announcement
media coverage
Conference & Event
Investors
information disclosure
corporate governance
Stock information
Investor relations liaison
Investor Interaction
CN
/
EN
Stock code
SSE: 603127
HKEX: 06127
Stock information
Zhaoyan new drug adheres to the principle of "serving drug innovation,
Focusing on the safety evaluation and monitoring of the whole life cycle of drugs,
To ensure the safety of medication
A
shares
H
shares